Kyle P. Chiang

机构：aTyr Pharma (United States)

发表论文 29 篇 · 总被引 2207 次 · h-index 20

代表论文

• Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use (2004 · Human Molecular Genetics · 被引 285)
• An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling (2006 · Chemistry & Biology · 被引 205)
• Human tRNA synthetase catalytic nulls with diverse functions (2014 · Science · 被引 126)
• Structure–Activity Analysis of Semisynthetic Nucleosomes: Mechanistic Insights into the Stimulation of Dot1L by Ubiquitylated Histone H2B (2009 · ACS Chemical Biology · 被引 122)
• Bisaryloxime Ethers as Potent Inhibitors of Transthyretin Amyloid Fibril Formation (2005 · Journal of Medicinal Chemistry · 被引 103)
• Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis:  Kinetic Stabilization of the Native State (2005 · Journal of the American Chemical Society · 被引 77)